BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29054455)

  • 21. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
    Xu R; Chen J; Cong X; Hu S; Chen X
    J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpressing cellular repressor of E1A-stimulated genes protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt.
    Deng J; Han Y; Yan C; Tian X; Tao J; Kang J; Li S
    Apoptosis; 2010 Apr; 15(4):463-73. PubMed ID: 19997978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. delta-Opioid receptor-stimulated Akt signaling in neuroblastoma x glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation.
    Heiss A; Ammer H; Eisinger DA
    Exp Cell Res; 2009 Jul; 315(12):2115-25. PubMed ID: 19362548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2,5-hexanedione induces bone marrow mesenchymal stem cell apoptosis via inhibition of Akt/Bad signal pathway.
    Sun J; Shi X; Li S; Piao F
    J Cell Biochem; 2018 Apr; 119(4):3732-3743. PubMed ID: 29236316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of intracerebroventricular application of the delta opioid receptor agonist [D-Ala2, D-Leu5] enkephalin on neurological recovery following asphyxial cardiac arrest in rats.
    Gao CJ; Li JP; Wang W; Lü BC; Niu L; Zhu C; Wei YY; Zhang T; Wu SX; Chai W; Li YQ
    Neuroscience; 2010 Jun; 168(2):531-42. PubMed ID: 20167252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quercetin protects oligodendrocyte precursor cells from oxygen/glucose deprivation injury in vitro via the activation of the PI3K/Akt signaling pathway.
    Wang XQ; Yao RQ; Liu X; Huang JJ; Qi DS; Yang LH
    Brain Res Bull; 2011 Oct; 86(3-4):277-84. PubMed ID: 21803128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lovastatin protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis through activation of PI3K/Akt and ERK1/2 signaling pathways].
    Xu RX; Chen X; Hu SS; Chen JH; Liu XW; Liu XB; Shi LH; Cong XF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Aug; 36(8):685-90. PubMed ID: 19100107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial ERK plays a key role in δ-opioid receptor neuroprotection against acute mitochondrial dysfunction.
    Zhu M; Li M; Yang F; Ou X; Ren Q; Gao H; Zhu C; Guo J
    Neurochem Int; 2011 Nov; 59(6):739-48. PubMed ID: 21864608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta opioid peptide [D-Ala2, D-Leu5] enkephalin (DADLE) triggers postconditioning against transient forebrain ischemia.
    Wang S; Duan Y; Su D; Li W; Tan J; Yang D; Wang W; Zhao Z; Wang X
    Eur J Pharmacol; 2011 May; 658(2-3):140-4. PubMed ID: 21349267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel cytoprotective peptide protects mesenchymal stem cells against mitochondrial dysfunction and apoptosis induced by starvation via Nrf2/Sirt3/FoxO3a pathway.
    Wang S; Zhang C; Niyazi S; Zheng L; Li J; Zhang W; Xu M; Rong R; Yang C; Zhu T
    J Transl Med; 2017 Feb; 15(1):33. PubMed ID: 28202079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways.
    Zhang Z; Li S; Cui M; Gao X; Sun D; Qin X; Narsinh K; Li C; Jia H; Li C; Han Y; Wang H; Cao F
    Basic Res Cardiol; 2013 Mar; 108(2):333. PubMed ID: 23386286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
    Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury.
    Li J; Zhou J; Zhang D; Song Y; She J; Bai C
    J Cell Mol Med; 2015 Oct; 19(10):2341-51. PubMed ID: 26177266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [DADLE suppresses the proliferation of human liver cancer HepG2 cells by activation of PKC pathway and elevates the sensitivity to cis-diammine dichloridoplatium].
    Tang B; DU J; Gao ZM; Liang R; Sun DG; Jin XL; Wang LM
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):425-9. PubMed ID: 22967443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. delta-Opioid receptor stimulation enhances the growth of neonatal rat ventricular myocytes via the extracellular signal-regulated kinase pathway.
    Zhao M; Wang HX; Yang J; Su YH; Su RJ; Wong TM
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):97-102. PubMed ID: 18047635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LPA rescues ER stress-associated apoptosis in hypoxia and serum deprivation-stimulated mesenchymal stem cells.
    Li Z; Wei H; Liu X; Hu S; Cong X; Chen X
    J Cell Biochem; 2010 Nov; 111(4):811-20. PubMed ID: 20533299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A delta2-opioid agonist inhibits p38 MAPK and suppresses activation of murine macrophages.
    Husted TL; Govindaswami M; Oeltgen PR; Rudich SM; Lentsch AB
    J Surg Res; 2005 Sep; 128(1):45-9. PubMed ID: 15921696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of rat intestinal epithelial cells from ischemia/reperfusion injury by (D-Ala2, D-Leu5)-enkephalin through inhibition of the MKK7-JNK signaling pathway.
    Wang Z; Tang B; Tang F; Li Y; Zhang G; Zhong L; Dong C; He S
    Mol Med Rep; 2015 Sep; 12(3):4079-4088. PubMed ID: 26126577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifaceted Effects of Delta Opioid Receptors and DADLE in Diseases of the Nervous System.
    Lee JY; Liska MG; Crowley M; Xu K; Acosta SA; Borlongan CV; Guedes VA
    Curr Drug Discov Technol; 2018; 15(2):94-108. PubMed ID: 29032758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [D-Ala
    Beal EW; Kim JL; Reader BF; Akateh C; Maynard K; Washburn WK; Zweier JL; Whitson BA; Black SM
    J Surg Res; 2019 Sep; 241():323-335. PubMed ID: 31071481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.